215 related articles for article (PubMed ID: 25502635)
61. Long-term follow-up of autologous bone marrow transplantation in patients with relapsed follicular lymphoma.
Freedman AS; Neuberg D; Mauch P; Soiffer RJ; Anderson KC; Fisher DC; Schlossman R; Alyea EP; Takvorian T; Jallow H; Kuhlman C; Ritz J; Nadler LM; Gribben JG
Blood; 1999 Nov; 94(10):3325-33. PubMed ID: 10552941
[TBL] [Abstract][Full Text] [Related]
62. Results of a randomized trial comparing high-dose chemotherapy plus Auto-SCT and R-FC in CLL at diagnosis.
Magni M; Di Nicola M; Patti C; Scimè R; Mulè A; Rambaldi A; Intermesoli T; Viero P; Tarella C; Gueli A; Bergui L; Trentin L; Barzan A; Benedetti F; Ambrosetti A; Di Raimondo F; Chiarenza A; Parvis G; Billio A; Attolico I; Olivieri A; Montanari M; Carlo-Stella C; Matteucci P; Devizzi L; Guidetti A; Viviani S; Valagussa P; Gianni AM
Bone Marrow Transplant; 2014 Apr; 49(4):485-91. PubMed ID: 24442244
[TBL] [Abstract][Full Text] [Related]
63. High-dose therapy followed by autologous purged stem-cell transplantation and doxorubicin-based chemotherapy in patients with advanced follicular lymphoma: a randomized multicenter study by GOELAMS.
Deconinck E; Foussard C; Milpied N; Bertrand P; Michenet P; Cornillet-LeFebvre P; Escoffre-Barbe M; Maisonneuve H; Delwail V; Gressin R; Legouffe E; Vilque JP; Desablens B; Jaubert J; Ramee JF; Jenabian A; Thyss A; Le Pourhiet-Le Mevel A; Travade P; Delepine R; Colombat P;
Blood; 2005 May; 105(10):3817-23. PubMed ID: 15687232
[TBL] [Abstract][Full Text] [Related]
64. Finalization of autologous stem cell transplant in complex and multirelapsed follicular lymphoma.
Carella M; Stefoni V; Pellegrini C; Argnani L; Cavo M; Zinzani PL
Tumori; 2020 Dec; 106(6):NP5-NP8. PubMed ID: 32442038
[TBL] [Abstract][Full Text] [Related]
65. [Advances in management of follicular lymphoma].
Zinzani PL
Rinsho Ketsueki; 2014 Oct; 55(10):1937-40. PubMed ID: 25297758
[No Abstract] [Full Text] [Related]
66. Controversies in the treatment of lymphoma with autologous transplantation.
Moskowitz AJ; Moskowitz CH
Oncologist; 2009 Sep; 14(9):921-9. PubMed ID: 19737999
[TBL] [Abstract][Full Text] [Related]
67. Prospective noninterventional study on peripheral blood stem cell mobilization in patients with relapsed lymphomas.
van Gorkom G; Finel H; Giebel S; Pohlreich D; Shimoni A; Ringhoffer M; Sucak G; Schaap N; Dreger P; Sureda A; Schouten HC
J Clin Apher; 2017 Oct; 32(5):295-301. PubMed ID: 27614935
[TBL] [Abstract][Full Text] [Related]
68. Successful in vivo purging of CD34-containing peripheral blood harvests in mantle cell and indolent lymphoma: evidence for a role of both chemotherapy and rituximab infusion.
Magni M; Di Nicola M; Devizzi L; Matteucci P; Lombardi F; Gandola L; Ravagnani F; Giardini R; Dastoli G; Tarella C; Pileri A; Bonadonna G; Gianni AM
Blood; 2000 Aug; 96(3):864-9. PubMed ID: 10910898
[TBL] [Abstract][Full Text] [Related]
69. High-dose chemotherapy followed by autologous and allogeneic hematopoietic stem cell transplantation in patients with follicular non-Hodgkin’s lymphoma in the rituximab era.
Escobar IG; Sánchez de Ibarguen BC; de Juan VC; Alonso CM; García MM; Ruíz AC; Pulla MP
Tumori; 2015; 101(1):2-7. PubMed ID: 25702654
[TBL] [Abstract][Full Text] [Related]
70. Results of R-ESHAP as salvage therapy in refractory/relapsed follicular lymphoma: a real-world experience on behalf of GELCAB group.
Muntañola A; Baumann T; Caballero AC; Sánchez-González B; Mercadal S; Escoda L; Soler A; Iserte L; Canet M; Villalobos MT; Magnano L; Sorigué M; García O; Salar A; López-Guillermo A; Sancho JM
Ann Hematol; 2020 Jul; 99(7):1627-1634. PubMed ID: 32451707
[TBL] [Abstract][Full Text] [Related]
71. PET/CT before autologous stem cell transplantation predicts outcome in refractory/relapsed follicular lymphoma.
Alcantara M; Dupuis J; Mareschal S; Julian A; Cottereau AS; Becker S; Dubois S; Oberic L; Huynh A; Meignan M; Laurent G; Tilly H; Haioun C; Ysebaert L
Eur J Nucl Med Mol Imaging; 2015 Feb; 42(2):215-21. PubMed ID: 25239490
[TBL] [Abstract][Full Text] [Related]
72. Peripheral blood stem cell CD34+ autologous transplant in relapsed follicular lymphoma.
Marin GH; Dal Cortivo L; Cayuela JM; Marolleau JP; Pautier P; Cojean-Zelek I; Brice P; Makke J; Benbunan M; Gisselbrecht C
Hematol Cell Ther; 1997 Feb; 39(1):33-40. PubMed ID: 9088936
[TBL] [Abstract][Full Text] [Related]
73. Comparison of autologous and allogeneic hematopoietic stem cell transplantation for follicular lymphoma.
van Besien K; Loberiza FR; Bajorunaite R; Armitage JO; Bashey A; Burns LJ; Freytes CO; Gibson J; Horowitz MM; Inwards DJ; Marks DI; Martino R; Maziarz RT; Molina A; Pavlovsky S; Pecora AL; Schouten HC; Shea TC; Lazarus HM; Rizzo JD; Vose JM
Blood; 2003 Nov; 102(10):3521-9. PubMed ID: 12893748
[TBL] [Abstract][Full Text] [Related]
74. Quantifying Benefit of Autologous Transplantation for Relapsed Follicular Lymphoma Patients via Instrumental Variable Analysis.
Oh DH; Li H; Duan Q; Villa D; Peters A; Chua N; Owen CJ; Connors JM; Stewart DA
Biol Blood Marrow Transplant; 2016 May; 22(5):941-8. PubMed ID: 26785331
[TBL] [Abstract][Full Text] [Related]
75. Autologous Stem Cell Transplantation for Patients with Early Progression of Follicular Lymphoma: A Follow-Up Study of 2 Randomized Trials from the German Low Grade Lymphoma Study Group.
Jurinovic V; Metzner B; Pfreundschuh M; Schmitz N; Wandt H; Keller U; Dreger P; Dreyling M; Hiddemann W; Unterhalt M; Hoster E; Weigert O
Biol Blood Marrow Transplant; 2018 Jun; 24(6):1172-1179. PubMed ID: 29605716
[TBL] [Abstract][Full Text] [Related]
76. Impact of the use of autologous stem cell transplantation at first relapse both in naive and previously rituximab exposed follicular lymphoma patients treated in the GELA/GOELAMS FL2000 study.
Le Gouill S; De Guibert S; Planche L; Brice P; Dupuis J; Cartron G; Van Hoof A; Casasnovas O; Gyan E; Tilly H; Fruchart C; Deconinck E; Fitoussi O; Gastaud L; Delwail V; Gabarre J; Gressin R; Blanc M; Foussard C; Salles G;
Haematologica; 2011 Aug; 96(8):1128-35. PubMed ID: 21486862
[TBL] [Abstract][Full Text] [Related]
77. Long-term follow-up of autologous peripheral blood hematopoietic stem cell transplantation for refractory lupus nephritis-a series study of 20 patients.
Yang L; Ren G; Chen W; Zhao L; Guo J; Ge Y; Zeng C; Hu W; Huang X; Zhang H
Lupus; 2022 Nov; 31(13):1586-1594. PubMed ID: 36117428
[TBL] [Abstract][Full Text] [Related]
78. Autologous transplant of follicular lymphoma in the era of rituximab.
Witzens-Harig M; Dreger P
Leuk Lymphoma; 2010 Jun; 51(6):967-74. PubMed ID: 20443675
[TBL] [Abstract][Full Text] [Related]
79. Long-term follow-up demonstrates curative potential of autologous stem cell transplantation for relapsed follicular lymphoma.
Puckrin R; Chua N; Chin K; Peters A; Duggan P; Shafey M; Storek J; Jamani K; Owen C; Stewart D
Br J Haematol; 2023 Apr; 201(2):319-325. PubMed ID: 36625160
[TBL] [Abstract][Full Text] [Related]
80. The potential benefit of allogeneic over autologous transplantation in patients with very early relapsed and refractory follicular lymphoma with prior remission duration of ≤12 months.
Lunning MA; Migliacci JC; Hilden P; Devlin SM; Castro-Malaspina H; Giralt S; Perales MA; Zelenetz AD; Moskowitz CH; Sauter CS
Br J Haematol; 2016 Apr; 173(2):260-4. PubMed ID: 26847389
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
